Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(7), P. 2306 - 2306
Published: March 28, 2025
Acute Kidney Injury (AKI) is a severe clinical condition featured by rapid decrease in kidney function short period of time. AKI, which often secondary to sepsis, ischemia-reperfusion and drug toxicity, associated high morbidity mortality. Moreover, it contributes the development chronic disease (CKD), due maladaptive or incomplete repair mechanisms, resulting renal fibrosis. Small non-coding RNA has recently emerged as novel biomarker for early detection treatment AKI. In particular, microRNAs (miRNAs) are molecules 21-25 nucleotides regulating expression protein-coding genes through sequence-specific recognition. Due their stability biological fluids, such urine plasma, they can be reliably analyzed quantified, this reason considered potential diagnostic therapeutic biomarkers. Specifically, miRNAs have been demonstrated predict AKI before increase creatinine levels, thus improving management syndrome. review, we provide comprehensive overview role urinary plasma
Language: Английский